Literature DB >> 2016728

Quinazolinone cholecystokinin-B receptor ligands.

M J Yu1, K J Thrasher, J R McCowan, N R Mason, L G Mendelsohn.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 2016728     DOI: 10.1021/jm00108a040

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  4 in total

1.  Cholecystokinin facilitates glutamate release by increasing the number of readily releasable vesicles and releasing probability.

Authors:  Pan-Yue Deng; Zhaoyang Xiao; Archana Jha; David Ramonet; Toshimitsu Matsui; Michael Leitges; Hee-Sup Shin; James E Porter; Jonathan D Geiger; Saobo Lei
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

2.  Discovery of the cyclotide caripe 11 as a ligand of the cholecystokinin-2 receptor.

Authors:  Mohammad Sadegh Taghizadeh; Bernhard Retzl; Edin Muratspahić; Christoph Trenk; Emilio Casanova; Ali Moghadam; Alireza Afsharifar; Ali Niazi; Christian W Gruber
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

3.  Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro.

Authors:  Samuel B Kombian; Kethireddy V V Ananthalakshmi; Subramanian S Parvathy; Wandikayi C Matowe
Journal:  J Physiol       Date:  2003-12-12       Impact factor: 5.182

4.  Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.

Authors:  Santiago J Ballaz; Michel Bourin; Huda Akil; Stanley J Watson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-09-14       Impact factor: 5.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.